Search Results - "Farre Bernado, N."

PO-1083 Real world data of peer review rounds on a daily basis: A nine-year experience by Rojas Cordero, J.V., Jornet Sala, N., Majercakova, K., Otero Pla, E., Farre Bernado, N., Pedro Olive, A., Mera Errasti, A., Soto Cambres, A.M, Montezuma Nino, L., Rabi Mitre, S.J., Sancho Pardo, G.

Get full text

412P Surgery and stereotactic ablative body radiotherapy for colorectal cancer lung oligometastases: One centre experience by Piedra-Cascon, A., Manrique, A.C. Virgili, Tellez, E. Martinez, Bernado, N. Farre, Trujillo, J.C., Serra, J. Balart, Garcia, A. Sebio, Szafranska, J., Sorolla, M. Aguado, Melo, P. Gallardo, Paez, D.

Get full text

1461P - NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Guirado, M., Majem, M., Massuti Sureda, B., de las Penas Bataller, R., Ortega Granados, A.L., Isla Casado, M.D., Domine Gomez, M., Marse Fabregat, R., Sala, M.A., Paredes Lario, A., Moran Bueno, M.T., Vazquez Estevez, S., Coves Sarto, J., Gonzalez-Larriba, J.L., Sanchez Torres, J.M., Vicente, D., Farre Bernado, N., Fernandez-Fornos, L., Varcarcel, F., Provencio, M.

“…CT-RT is the standard treatment for unresectable LA-NSCLC. P plus vinorelbine is widely used. Metronomic CT is a frequent administration of low doses of CT…”
Get full text

NORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Guirado, M., Majem, M., Massuti Sureda, B., de las Penas Bataller, R., Ortega Granados, A.L., Isla Casado, M.D., Domine Gomez, M., Marse Fabregat, R., Sala, M.A., Paredes Lario, A., Moran Bueno, M.T., Vazquez Estevez, S., Coves Sarto, J., Gonzalez-Larriba, J.L., Sanchez Torres, J.M., Vicente, D., Farre Bernado, N., Fernandez-Fornos, L., Varcarcel, F., Provencio, M.

Get full text

1461PNORA trial (GECP 15/02): Updated results of the Spanish Lung Cancer Group (SLCG) phase II trial of concurrent chemo-radiotherapy (CT-RT) with cisplatin (P) plus metronomic oral vinorelbine (mOV) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Guirado, M, Majem, M, Massuti Sureda, B, de las Penas Bataller, R, Ortega Granados, A L, Isla Casado, M D, Domine Gomez, M, Marse Fabregat, R, Sala, M A, Paredes Lario, A, Moran Bueno, M T, Vazquez Estevez, S, Coves Sarto, J, Gonzalez-Larriba, J L, Sanchez Torres, J M, Vicente, D, Farre Bernado, N, Fernandez-Fornos, L, Varcarcel, F, Provencio, M

“…Abstract Background CT-RT is the standard treatment for unresectable LA-NSCLC. P plus vinorelbine is widely used. Metronomic CT is a frequent administration of…”
Get full text

PO-1253 Lung metastases from different primary tumors treated with Stereotactic ablative radiotherapy by Rojas Cordero, J.V., Sancho Pardo, G., Majercakova, K., Gallego Franco, P., Carrasco de Fez, P., Soto Cambres, A.M., Balart Serra, J., Farré Bernadó, N.

Get full text

EP-1619 DOSIMETRIC IMPACT OF 4DCT IN LOCALLY ADVANCED NSCLC TREATMENT PLANNING by de Segura Melcón, G. Gómez, Bernadó, N. Farré, Salvador, G. Ferrandis, Grau, O. Parés, Martinez, S. Bermejo, Fez, P. Carrasco de

Get full text